Ridgecrest Wealth Partners’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-760
Closed -$43.7K 119
2025
Q2
$43.7K Buy
760
+160
+27% +$12.8K 0.02% 111
2025
Q1
$65K Buy
+600
New +$52.2K 0.03% 112

Other funds holding AGL

Ridgecrest Wealth Partners's AGL Position: Q3 2025 in Review

Ridgecrest Wealth Partners sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 760 shares — an estimated $43.7K sold.

Ridgecrest Wealth Partners first reported a position in AGL in Q1 2025 and held it in 2 quarters. The position peaked at $65K in Q1 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Ridgecrest Wealth Partners reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Ridgecrest Wealth Partners sold 760 Agilon Health shares in Q3 2025, an estimated $43.7K.
  • Ridgecrest Wealth Partners first reported a position in Agilon Health in Q1 2025 and held it in 2 quarters.
  • Ridgecrest Wealth Partners's Agilon Health position peaked at $65K in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Ridgecrest Wealth Partners's 13F filing for Q3 2025, filed 14 Oct 2025.